WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke NOAELTAXEL wurde als Wortmarke am 16.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1542200 |
| Länder | 
|
| Basismarke |
Nr. 4020200100906,
15. Juni 2020
|
| Anmeldedatum | 16. Juni 2020 |
| Ablaufdatum | 23. September 2021 |
Markeninhaber
B-455, 52, Ewhayeodae-gil,
Seodaemun-gu
KR
Seodaemun-gu
KR
Markenvertreter
602, 23-6, Baumoe-ro 37-gil Seocho-gu
Seoul 06744
KR
Waren und Dienstleistungen
05
Medicines for the treatment of gastrointestinal diseases;
injectable mineral solutions for medical purposes;
antioxidants for medical purposes; haematogen;
pharmaceutical preparations for tumor treatment;
multivitamin preparations; suppositories; pharmaceutical
preparations acting on the central nervous system;
pharmaceutical preparations for diagnosis; sedatives;
analgesics; vaginal washes for medical purposes;
pharmaceutical preparations for treating asthma; medicines
for dental purposes; haemorrhoid preparations;
pharmaceutical preparations for inhalation for the treatment
of pulmonary hypertension; vaccines against pneumococcal
infections; dermatological pharmaceutical products;
contraceptive preparations; antihypertensives; anti-uric
preparations; anti-diabetic pharmaceuticals; pharmaceutical
preparations for anus; antibiotic preparations; antibiotics;
anti-cancer preparations; anti-cancer treatment supplements;
antidepressants; anticoagulants; antineoplastics;
anti-dermoinfectives; antidotes; antipyretic analgesics;
febrifuges; vasoconstrictors; hypoglycemic agents; blood
thinners; pharmaceutical preparations for respiratory
organs; respiratory stimulants; Pharmaceutical preparations;
pharmaceutical agents affecting sensory organs; thyroid and
para-thyroid hormone preparations; tonics [medicines]; oral
contraceptive pills; antiemetics; local anesthetics;
bronchodilating preparations; anti-cough drops; androgen
preparations; pituitary hormone preparations; pharmaceutical
preparations for treating diabetes; pharmaceutical agents
affecting metabolism; vaccines against flu; chilblain
preparations; pharmaceutical preparations for headache;
anaesthetics; pharmaceutical agents affecting peripheral
nervous system; pharmaceutical preparations for immunity
adjustment; nutritive substances for microorganisms;
pharmaceutical for the treatment of erectile dysfunction;
pharmaceutical preparations for urogenital organs; vitamin
preparations; pharmaceutical products for the treatment of
bone diseases; anti-inflammatory and antipyretic
preparations; pharmaceutical agents affecting digestive
organs; cardiovascular pharmaceutical preparations;
nervines; ophthalmic preparations; allergy medications;
chemico-pharmaceutical preparations; inhaled pharmaceutical
preparations for the treatment of respiratory diseases and
disorders; pharmaceutical products for treating respiratory
diseases and asthma; mixed vitamin preparations;
preparations for the treatment of burns; disinfectants for
chemical toilets; chemotherapeutics; preparations for
treatment of hepatitis; preparations for treating colds;
preparations for the treatment of hyperlipidemia;
preparations for the treatment of hypercholesteremia;
pharmaceutical preparations for treating hypertension;
pharmaceutical preparations for the treatment of
osteoporosis; preparations for the treatment of
osteoporosis; injectable pharmaceuticals for treatment of
anaphylactic reactions; pharmaceutical preparations for
treating halitosis; nausea treatment preparations;
antiulcerants; pharmaceutical preparations for the treatment
of musculoskeletal disorders; preparations for the treatment
of muscle fatigue; pharmaceutical preparations for treating
chloasma; pharmaceutical preparations for the treatment of
diseases of the endocrine system; pharmaceutical
preparations for the treatment of eye diseases and
conditions; pharmaceutical preparations for treating
metabolic disorders; pharmaceutical preparations for
treating peripheral nervous system disorders; pharmaceutical
preparations for the treatment of dandruff; pharmaceutical
preparations for the treatment of rhinitis; radioactive
pharmaceutical preparations for in vivo diagnostics or
therapeutic use; pharmaceutical preparations for the
treatment of cells; medicines for treating intestinal
disorders; cardiovascular treatment preparations;
pharmaceutical preparations for the treatment of kidney
diseases; pharmaceutical preparations for the treatment of
disorders of the metabolic system; pharmaceutical
preparations for treating allergies; pharmaceutical
preparations and compositions for the treatment and
prevention of cancer; biopharmaceuticals for the treatment
of cancer; pharmaceutical products for the treatment of
cancer; pharmaceutical preparations for the treatment of
inflammatory disorders; pharmaceutical preparations and
substances for the treatment of gastro-intestinal diseases;
medicated mouth treatment preparations; transdermal patches
for medical treatment; pharmaceutical preparations for the
treatment of gout; drug delivery agents; drug delivery
agents consisting of compounds that facilitate delivery of a
wide range of pharmaceuticals; drug delivery agents in the
form of powders that provide controlled release of the
active ingredients for a wide variety of pharmaceuticals;
drug delivery agents in the form of tablets that provide
controlled release of the active ingredients for a wide
variety of pharmaceuticals; drug delivery agents in the form
of capsules that provide controlled release of the active
ingredients for a wide variety of pharmaceuticals; drug
delivery agents that facilitate the delivery of
pharmaceutical preparations; drug delivery agents in the
form of dissolvable films that facilitate the delivery of
pharmaceutical preparations; delivery agents in the form of
dissolvable films that facilitate the delivery of
nutritional supplements; drug delivery agents in the form of
coatings for tablets that facilitate the delivery of
pharmaceutical preparations; delivery agents in the form of
coatings for tablets that facilitate the delivery of
nutritional supplements
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. Mai 2022 | 2022/19 Gaz | US | Ablehnung |
| 07. Februar 2022 | 2022/10 Gaz | KR | RAW: Total Ceasing Effect |
| 22. Januar 2022 | 2022/9 Gaz | AU | Ablehnung |
| 29. Juli 2021 | 2021/30 Gaz | JP | Ablehnung |
| 14. Dezember 2020 | 2020/52 Gaz | IN | Ablehnung |
| 10. Dezember 2020 | 2020/51 Gaz | EM | Ablehnung |
| 10. November 2020 | 2020/46 Gaz | CN | Ablehnung |
| 05. November 2020 | 2020/46 Gaz | RU | Ablehnung |
| 19. Oktober 2020 | 2020/43 Gaz | US | Ablehnung |
| 15. Oktober 2020 | 2020/43 Gaz | AU | Ablehnung |
| 16. Juni 2020 | 2020/28 Gaz | KR | Eintragung |
ID: 141542200